Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Cinchona Micrantha Extract

    • Product Name Cinchona Micrantha Extract
    • Alias Quinine
    • Einecs 94349-61-6
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    489997

    botanical_name Cinchona micrantha
    common_name Cinchona Micrantha Extract
    plant_part_used Bark
    extraction_method Solvent extraction
    active_compounds Quinine, cinchonine, cinchonidine, quinidine
    appearance Brownish powder or liquid
    solubility Soluble in water and alcohol
    primary_use Antimalarial and antimicrobial
    origin Native to South America (Peru, Bolivia)
    pH_range 4.0 - 6.0
    storage_conditions Cool, dry place away from sunlight
    odor Characteristic bitter odor
    taste Very bitter
    shelf_life 2 years (when properly stored)
    typical_concentration 5% - 10% in formulations

    As an accredited Cinchona Micrantha Extract factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Cinchona Micrantha Extract, 500g, packed in a sealed, opaque plastic container with tamper-evident cap and clear labeling.
    Shipping Cinchona Micrantha Extract is shipped in sealed, food-grade containers, protected from light, moisture, and heat. Packaging complies with international regulations for chemicals. Standard shipping is via air or sea freight, with all necessary documentation. Handling instructions and material safety data sheets (MSDS) accompany each shipment to ensure safe transit and storage.
    Storage Cinchona Micrantha Extract should be stored in a cool, dry, and well-ventilated area, away from direct sunlight and sources of ignition. Keep the container tightly closed and protected from moisture. Store at room temperature, ideally between 15°C and 25°C. Segregate from incompatible substances and ensure it is kept in clearly labeled, appropriate chemical storage containers.
    Application of Cinchona Micrantha Extract

    Applications of Cinchona Micrantha Extract in Industrial Manufacturing

    Cinchona micrantha extract, primarily valued for its quinoline alkaloids, serves a critical role as an active ingredient and processing aid across tightly regulated industries. Our direct manufacturing expertise ensures consistent quality and supply chain transparency, meeting the specialized requirements of established downstream sectors. Below, we present focused scenarios where cinchona extract is deployed, specifying integration standards, dosing practices, applied production stages, and resultant product profiles.

    1. Active Pharmaceutical Ingredient (API) for Antimalarial Drug Synthesis

    Leading pharmaceutical manufacturers source high-purity cinchona extract for the industrial preparation of quinine and its derivatives, a foundation for artemisinin-based combination therapies and other antimalarial agents. The extract’s alkaloid profile, content specification, and validated traceability align with rigorous industry and regulatory protocol, ensuring precise formulation and active moiety availability in final API manufacture. Direct incorporation typically follows extraction, alkaloid enrichment, and fractionation, preceding chemical modification or direct dosage formulation, based on the drug’s prescription and delivery system.

    Industry compliance standards

    • EU Pharmacopoeia (Ph. Eur.) quinine monograph
    • United States Pharmacopeia (USP) quinine and related compounds specifications
    • WHO Good Manufacturing Practices (GMP) for active pharmaceutical ingredients
    • International Council for Harmonisation (ICH Q7, Q3A, Q3C) for impurities, residual solvents, and finished APIs

    Typical usage ratio

    • Alkaloid concentrations adjusted to 10–40% (by weight of input batch), actual addition rate determined by target API purity and total synthesis route requirements

    Downstream process integration

    • Batch-wise extract enters post-extraction isolation—fractionation and concentration—prior to direct synthesis or chemical derivatization of quinine derivatives

    Final product types

    • Quinine sulfate tablets
    • Dihydroquinine capsules
    • Injectable quinine solutions
    • Antimalarial combination therapy APIs

    2. Food and Beverage Ingredient for Bitter Flavoring

    Regulated beverage and specialty food manufacturers utilize cinchona extract as a botanical bittering agent, most notably in tonic water and certain aperitifs. The extract imparts a characteristic bitter profile derived from its natural quinine content, strictly controlled under global food safety legislation. Integration occurs during controlled blending or post-filtration dosing, with alkaloid levels titrated against regulatory maxima and desired sensory balance. Finished products undergo total quinine content verification as part of release QC.

    Industry compliance standards

    • EU Commission Regulation (EC) No 1334/2008 on flavorings
    • FDA 21 CFR 172.575 (quinin-containing flavoring for use in foods)
    • Codex Alimentarius Standard 192–1995 (food additive permitted levels)
    • Good Manufacturing Practice (GMP) certification for food processing

    Typical usage ratio

    • 5–100 mg/L total quinine base equivalent, never exceeding regulatory maximums (e.g., 83 mg/L in US tonic water per FDA)

    Downstream process integration

    • Addition during post-extraction liquid dosing to beverage concentrate or syrup bases before final dilution and filling

    Final product types

    • Tonic waters
    • Bitter sodas
    • Cocktail bitters
    • Alcoholic aperitifs

    3. Veterinary Formulation Intermediate for Ectoparasite Treatment

    The animal health sector adopts cinchona extract as an active botanical intermediate in the compounding of topical ectoparasiticide products. Its natural alkaloid mix targets insect nervous systems, enabling use in regulated external liquid formulations for livestock and companion animals. Downstream producers route the extract through aqueous or emulsion blending, followed by quality-assured batch homogenization and sterile filtration to ensure uniform bioactivity and animal safety compliance.

    Industry compliance standards

    • VICH GL42 Good Manufacturing Practice for veterinary pharmaceutical products
    • National animal health product monographs (e.g., European Medicines Agency CVMP standards for botanicals)
    • ISO 9001:2015 quality management in veterinary formulations

    Typical usage ratio

    • 0.25–2% by weight (in emulsified or aqueous base), proportion set by target species sensitivity and regional veterinary regulations

    Downstream process integration

    • Batch incorporation in the active ingredient blending stage before product homogenization, filling, and sterilization

    Final product types

    • Topical antiparasitic lotions
    • Pour-on cattle ectoparasiticides
    • Pet-specific spot-on solutions

    4. Analytical Standard and Reference Substance for Quality Control

    Quality assurance laboratories and downstream pharmaceutical QC departments employ our cinchona extract as a reference material for standardization of analytical test methods. The calibrated quinoline alkaloid spectrum provides traceable benchmarks in HPLC, NMR, and titrimetric assays, underpinning reliable quantification of botanical APIs in regulatory dossier submissions. Laboratories incorporate the standardized extract during calibration curve preparation or system suitability verification before routine release and stability assays.

    Industry compliance standards

    • European Pharmacopoeia and USP analytical reference substance guidelines
    • ISO/IEC 17025 laboratory accreditation for test method validation
    • ICH Q2 (R2) validation of analytical procedures

    Typical usage ratio

    • 10–100 μg/mL or as specified within reference standard method, set according to instrument sensitivity, matrix, and calibration design

    Downstream process integration

    • Introduction during laboratory standard solution preparation and method calibration prior to active pharmaceutical ingredient quantification

    Final product types

    • Lab-certified analytical reference standards
    • Calibration sets for HPLC, NMR, and UV methods
    • QC assay kits for production site monitoring

    5. Botanical Source for Industrial Alkaloid Extraction in Fine Chemical Synthesis

    Downstream fine chemical processors utilize cinchona extract as a primary plant source for quinoline alkaloid isolation, which supports large-scale chemical synthesis of advanced organic intermediates. Its integration includes solvent partitioning, column chromatography, and alkaloid modification steps that maximize yield and purity for specialty chemicals and synthesis reagents. The extract’s batch traceability and consistent alkaloid ratio enhance process efficiency and reproducibility for industrial clients requiring high-purity chemical feedstock.

    Industry compliance standards

    • REACH Registration under EU chemicals regulation (EC) No 1907/2006
    • ISO 9001:2015 for fine chemical processing
    • Internal GMP-like standards for chemical purification

    Typical usage ratio

    • Feedstock input based on targeted alkaloid yield—usually 5–30% processed extract per step, optimized against downstream synthesis route and purity requirements

    Downstream process integration

    • Initial charge to solvent extraction systems before chromatographic separation and prep-scale chemical transformation

    Final product types

    • Quinoline hydrohalides
    • Chiral ligands for asymmetric synthesis
    • Pharmaceutical intermediate building blocks
    Free Quote

    Competitive Cinchona Micrantha Extract prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Cinchona Micrantha Extract: Experience from the Source

    Producing Cinchona Micrantha Extract: Perspective from Our Factory Floor

    Having spent decades in the business of plant extraction, I’ve watched countless ingredients cycle through phases of demand. Cinchona micrantha remains different. Our team interacts directly with the raw Peruvian bark every season; we know exactly what effort goes into converting a harvested product into a standardized extract fit for health products, beverages, and even fine laboratories. This isn’t just another commodity for us. There’s a legacy woven into every kilogram, and extracting that essence is more than a process—it’s a balancing act that calls for technical know-how and field experience.

    What Goes into Our Cinchona Micrantha Extract

    Cinchona micrantha comes from one of the original anti-malarial plants, valued for a spectrum of alkaloids—most famously quinine. Widow in color, fibrous and tough, the bark itself never yields easily. Every batch starts with established, identifiable botanical sources. Wild-crafting raises a lot of quality concerns, which is why our buyers and collection partners stick only to mapped regions and identified stands, without depleting the forest irreversibly. Traceability means a lot in our plant, so we refuse to touch mixed or unidentified origins.

    Inside the factory, skilled operators disassemble the bark through milling, and then send it through a solvent extraction system we’ve been optimizing for decades. To us, water alone never draws out the full alkaloid profile, so we use ethanol blends adjusted for the season’s humidity, temperature, and bark density, yielding a concentrated extract. Every manufacturing run records several parameters—solvent strength, extraction time, bark weight, temperatures—because an under- or over-extracted batch creates downstream issues.

    The finished extract shows a reddish-brown profile, with total alkaloid content generally between 4% and 6%, though we sometimes run special orders concentrated to 10% alkaloids. Our main product model for labs and large-scale health manufacturers averages 5.4%, with sub-fractionation protocols available for pharmaceutical clients after individual alkaloids such as quinine, quinidine, or cinchonidine. We double-check every batch using spectrophotometry and TLC, holding extracts if they show too high a level of tanin or any contaminants above our own internal standards.

    Performance: Applications and Working Experience

    Cinchona micrantha extract finds its place most often in pharmaceutical and beverage applications. There are plenty of reasons for this. Quinine serves as one of the world’s oldest antimalarials, but chemists and beverage formulators also admire the complex, bitter twang it brings to tonic waters and other crafted drinks. In the hands of formulators, this extract broadens the functional palette, both as a flavoring and a bioactive. You cannot achieve this kind of bitterness using synthetic substitutes or easily sourced bitterants—the alkaloid spectrum, combined with volatile oils, delivers something wholly distinct.

    Tablet-makers have their own set of priorities. Compressibility and flow are key, and unless your extract has a uniform moisture balance, the end product can dust, clump, or crack. We engineer ours with a controlled drying curve to minimize fines and help the extract blend properly into solid dosage forms. This does not come from wishful thinking; we’ve learned by hands-on experience that pushing the drying phase too quickly invites caking, so we stick to slow, low-temperature protocols.

    For beverage clients, flavor consistency is everything. Switch bark lots, miss a step in the filtration, or store product in the wrong humidity, and you risk cloudy mixers that fail the visual standard. This has happened before, and driven by those headaches, we now operate a two-stage filtration line—removing excess lipids and polyphenols—to yield an extract that won’t cause haze or sedimentation, even after months in glass. These may sound like small details, but they create real headaches at scale.

    How Cinchona Micrantha Compares to Other Plant Extracts

    Many buyers new to Cinchona micrantha see cinchona extract and imagine any bitter bark will get the job done. This attitude ignores the specialized role of different alkaloid profiles. Take gentian root or quassia bark—they offer their own bittering compounds but lack quinine’s distinct molecular punch, neither having the same physiological effects nor regulatory status in most drug or beverage markets. Synthetic quinine can be produced, but we find that clients committed to authenticity and transparency in labelling stay with botanical origin.

    Cinchona officinalis and Cinchona ledgeriana also see usage in extract circles, and we have handled both in separate manufacturing lines. The key difference lies in alkaloid distribution. Micrantha barks often provide a wider quinine to cinchonidine ratio, with a slightly mellowed aroma and a less astringent taste, better suited for beverage production where too much bite turns away consumers. We process these species separately—not only for legal traceability, but because blending alters the flavor profile and stability.

    Some industrial processes favor purity over spectrum, opting for quinine sulfate crystals or heavily purified fractions. Our view, built from decades of dialogue with formulators and chemists, is that full-spectrum extracts play a different role. Along with the main alkaloid, minor components influence taste and even physiological absorption. This isn’t theoretical. Beverage companies inform us that older-style “wild” extract batches outperform pure quinine in sensory panels. We respect regulatory needs for purity, but reject the idea that everything must be reduced to a single compound. Product developers need options: pure, standardized fractions for pharma; whole extracts for beverage, health, and nutraceutical categories.

    Quality, Traceability, and Consumer Expectations

    Direct manufacturing control shapes how we respond to consumer concerns, regulatory requirements, and emerging trends—a luxury not afforded to traders or mere resellers. A rise in greenwashing and “botanical” claims has driven our clients to dig deeper into sourcing. We invite buyers to audit the harvesting process, inspect supplier documentation, and visit our factory floor. It’s easy to sell an extract on price, but that risks not only inconsistent flavor but real safety concerns. Years ago, a batch of “wild” cinchona extract in the market failed basic chromatography, testing positive for unrelated alkaloids and solvents. Incidents like these reinforce our policy of strict inputs, repeated in-house testing, and batch traceability.

    We also see increased requests for sustainability certification. We engage with harvesters trained in sustainable bark removal—preserving the tree, not felling it, to respect both the environment and future production. The effect is twofold: raw material supply remains stable, and extract quality remains consistent year on year. Our buyers value this assurance, particularly European and North American clients who must meet growing environmental and import controls. Documentation includes every step from forest to final shipping lot, available to auditors and regulatory agents without hesitation.

    Handling Challenges: Lessons from Production

    Extraction is not a paint-by-numbers exercise. Variation in rainfall, temperature swings, and even local politics can disrupt bark supply. In lean years, barks arrive thinner and lower in target alkaloids, so our manufacturing staff recalibrate the extraction parameters to maximize yield without sacrificing quality. While these adjustments can stress production schedules, we find that experience and readiness to adapt produce better results than rigidly applied procedures.

    A consistent challenge involves balancing filtration and downstream usability. Over-filtration removes color or aroma that defines Cinchona micrantha’s value in finished products. Insufficient processing runs the risk of grit, haze, or even unwanted microbial growth. Multiple rounds of process validation, including third-party lab confirmation, serve as ongoing checkpoints. In one case, a shipment delayed at port experienced a temperature spike—our own controls detected accelerated degradation, so we withdrew the batch, eating the loss but defending our reputation. Factories that skip these hard calls wind up with dissatisfied clients or worse, regulatory backlash.

    Machinery and operators play intertwined roles. We invest in maintenance of extraction vessels and in ongoing staff training. A poorly ground bark or an extractor left unwashed for a shift can overwrite months of crop planning. We treat each step with the same seriousness. Customers aren’t interested in excuses; they want reliability, and so do we. This focus on execution is what built trust with major end-users, many of whom started as skeptics after bad experiences with other suppliers.

    Solving Downstream Formulation Problems

    Our dialogue with clients does not end at shipping. Rarely does an extract slot perfectly into every formulation plan. Powder caking in a tablet line, off-flavors in a mixer, poor dispersibility in a supplement—these issues arise more often than marketing teams admit. Our technical staff fields these calls weekly, and often works directly with client R&D to tweak finished extract parameters—altering moisture, granulation, or even pH levels to suit different end uses.

    We introduced a fine-milled variant after a major European pharma partner struggled with filtration clogs. Some beverage producers now prefer our slightly less concentrated, lighter-hued version for clear tonic waters. These options grow directly from responding to real-world problems, not just internal or theoretical benchmarks. The extract must fit into the customer’s production, not the other way around.

    A true factory relationship means sharing this kind of troubleshooting. One fermentation company used to experience product instability from seasonal extract changes, resulting in variations batch to batch. Testing and subsequent adjustment of the extraction solvent ratio now provides stability from month to month—even with swings in raw bark alkaloid content. These lessons become part of every operational season, so repeat customers don’t face the same headaches time after time.

    The Value of Real-World Feedback

    I’ve seen many trends come and go in extract manufacturing, usually led by shifts in regulatory outlook, new clinical studies, or the latest ingredient fashion. Cinchona micrantha endures through these cycles because it’s supported by both a deep historical record and modern application demand. Our team keeps a dialogue open with clients—from multi-national beverage developers to small supplement producers—since feedback about application successes or problems translates directly into the improvements we make in sourcing, processing, or blending.

    Networking with buyers, formulators, and regulatory officials in person at international ingredient shows sharpens our approach. A beverage developer might demand “crystal clarity” for clear mixers, while a compounding pharmacist wants tighter control on alkaloid ratios. We serve both by separating manufacturing lots, fine-tuning extraction, or occasionally holding a run for further quality assurance. This is the practical side of manufacturing, rarely seen in flowcharts but always visible in client satisfaction.

    Market Insights and Industry Position

    The market for cinchona extracts does not operate in a vacuum. Trends in beverage popularity, pharmaceutical demand, and evolving botanical supplement regulations all shape volume and profile needs year by year. Even as synthetic alternatives grow, jobs such as authentic beverage formulation or traditional medicine production can’t rely solely on isolated or artificial versions. Many finalized products now compete not only on taste and efficacy, but also on ingredient origin, traceability, and authenticity—criteria that direct-from-production extract can meet honestly.

    As a direct manufacturer, we sit in a singular position with the ability to respond rapidly to these market needs. Distribution networks pass through layers of hands, but true differentiation happens inside the factory and at the raw material source. Years of working through harvest shortages, regulatory changes, and customer technical demands have forged resilience and ingenuity in our methods. Batch-by-batch logging, in-plant routine screening, and customer-facing customization separate functioning suppliers from companies just trading on the global spot market.

    Why Cinchona Micrantha Matters—And Who Needs the Real Thing

    Extract of Cinchona micrantha offers more than a set of numbers on a spec sheet. The reason formulators keep returning to genuine extract, rather than synthetic or lower-quality alternatives, centers around consumer expectation, safety, taste, and regulatory assurance. Our experience confirms the widespread demand for traditional, well-characterized extracts, especially as end consumers learn to read labels with more scrutiny. Pharmacopeial recognition, historical safety data, and a transparent chain of custody matter more now than ever.

    A copycat can sell based on price for a season, but persistent clients build partnerships on reliability, honesty, and demonstrated technical ability. Only by maintaining direct control over every stage—from bark selection to final packaging, and working shoulder to shoulder with the people blending, testing, and packaging—can a supplier deliver the consistency, quality, and performance that the market expects for health, pharmaceutical, and beverage industries.

    Looking Ahead: Sustaining Value and Improving Practice

    Plant extracts are not commodity chemicals—they are living, changing materials shaped by geography, season, and skilled human handling. As manufacturers, we constantly revisit every step of production, learning from every successful batch or setback. We commit to improving sustainability through field-level training and careful harvesting practices, reinforcing transparency at every step. Long-term supply stability means reinvesting in the local workforce, maintaining machinery, and staying open to evolving customer technical demands.

    Cinchona micrantha extract’s reputation rests not just on its chemistry or tradition, but on our ongoing commitment to quality, flexibility, and respect for both nature and the industries we serve. From our side of the factory wall, manufacturing extracts isn’t just about hitting a spec or filling a container. It’s a live conversation between field, laboratory, factory, and client—a process that challenges us to think, adapt, and deliver year in and year out.